RICHMOND, Va. (WRIC) — The Food and Drug Administration will hold a meeting on September 24 to review the data, safety and effectiveness of the birth control device Essure. The device is supposed to ...
WASHINGTON (MEDIA GENERAL) – After suffering symptoms of extreme pelvic pain, bleeding and migraines, former users of a birth control device known as Essure are pushing for Congress to immediately ...
Family planning can come with many questions, concerns and fears. Once a woman makes the personal decision to not or no longer have children, there are various types of birth control to consider and ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--Nov. 4, 2004--Conceptus, Inc. (NASDAQ:CPTS) announced today that the Centers for Medicare and Medicaid Services (CMS) has released the Final Rule for the 2005 ...
Essure birth control was first approved in 2002. — -- U.S. regulators said they would review a popular birth control implant device at a panel this week following multiple complaints. The implant ...
It’s the end of an era for Amanda Dykeman, one of the many women who has campaigned against the permanent contraceptive device Essure. Bayer, the device’s manufacturer, announced earlier this week ...
Essure began as an exciting new contraceptive option for women, but when adverse event reports began piling up, it became a focus of controversy and litigation. It has now been removed from the market ...
The threat of a hunger strike against the Food and Drug Administration, a Facebook page titled “Essure Problems Lawsuit” and a congressional bill calling for a recall of the female contraceptive ...
MOUNTAIN VIEW, Calif., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure ® procedure, the most effective non-surgical permanent birth control method available*, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results